{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T10:02:21Z","timestamp":1772100141957,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11886-025-02257-0","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T08:31:48Z","timestamp":1750667508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Use of Acetazolamide in People with Decompensated Heart Failure: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5068-7869","authenticated-orcid":false,"given":"Johana Elizabeth","family":"Erazo-Castillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1560-7207","authenticated-orcid":false,"given":"Juan Camilo","family":"Ramos-Pic\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2445-3680","authenticated-orcid":false,"given":"Johana Patricia","family":"Galv\u00e1n-Barrios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7498-5346","authenticated-orcid":false,"given":"Yelson Alejandro","family":"Pic\u00f3n-Jaimes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"issue":"1","key":"2257_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00059-023-05221-2","volume":"49","author":"J Bauersachs","year":"2024","unstructured":"Bauersachs J, Soltani S. Heart failure: update of the ESC 2023 guidelines. Herz. 2024;49(1):19\u201321.","journal-title":"Herz"},{"issue":"43","key":"2257_CR2","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1093\/eurheartj\/ehab791","volume":"42","author":"F Crea","year":"2021","unstructured":"Crea F. Mechanisms of heart failure with preserved ejection fraction, risk stratification of heart failure with reduced ejection fraction, and new light on resistance to diuretics in acute decompensated heart failure. Eur Heart J. 2021;42(43):4405\u20139.","journal-title":"Eur Heart J"},{"key":"2257_CR3","doi-asserted-by":"crossref","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. Gu\u00eda ESC 2021 sobre El Diagn\u00f3stico y Tratamiento de La insuficiencia cardiaca Aguda y cr\u00f3nica. Rev Esp Cardiol. 2022;75(6):e5231\u2013523114.","DOI":"10.1016\/j.recesp.2021.11.012"},{"issue":"5","key":"2257_CR4","doi-asserted-by":"publisher","first-page":"728","DOI":"10.7326\/M23-0349","volume":"176","author":"J Zarconi","year":"2023","unstructured":"Zarconi J. Heart failure. Ann Intern Med. 2023;176(5):728\u20139.","journal-title":"Ann Intern Med"},{"issue":"1","key":"2257_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2174\/157340211501190129144451","volume":"15","author":"MA Chaudhry","year":"2019","unstructured":"Chaudhry MA. Heart failure. Curr Hypertens Rev. 2019;15(1):7.","journal-title":"Curr Hypertens Rev"},{"issue":"5","key":"2257_CR6","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.jchf.2024.02.020","volume":"12","author":"JW Ostrominski","year":"2024","unstructured":"Ostrominski JW, De Filippis EM, Bansal K, Riello RJ, Bozkurt B, Heidenreich PA, et al. Contemporary American and European guidelines for heart failure management: JACC: heart failure guideline comparison. JACC Heart Fail. 2024;12(5):810\u201325.","journal-title":"JACC Heart Fail"},{"issue":"44","key":"2257_CR7","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.1093\/eurheartj\/ehad617","volume":"44","author":"B Deniau","year":"2023","unstructured":"Deniau B, Costanzo MR, Sliwa K, Asakage A, Mullens W, Mebazaa A. Acute heart failure: current Pharmacological treatment and perspectives. Eur Heart J. 2023;44(44):4634\u201349.","journal-title":"Eur Heart J"},{"issue":"37","key":"2257_CR8","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","volume":"44","author":"TA McDonagh","year":"2023","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, et al. 2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;44(37):3627\u201339.","journal-title":"Eur Heart J"},{"issue":"7","key":"2257_CR9","doi-asserted-by":"publisher","first-page":"e3587","DOI":"10.3390\/ijms23073587","volume":"23","author":"K Nakamura","year":"2022","unstructured":"Nakamura K, Miyoshi T, Yoshida M, Akagi S, Saito Y, Ejiri K, et al. Pathophysiology and treatment of diabetic cardiomyopathy and heart failure in patients with diabetes mellitus. Int J Mol Sci. 2022;23(7):e3587.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2257_CR10","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1161\/CIRCRESAHA.121.318186","volume":"128","author":"JN Njoroge","year":"2021","unstructured":"Njoroge JN, Teerlink Jr. Pathophysiology and therapeutic approaches to acute decompensated heart failure. Circ Res. 2021;128(10):1468\u201386.","journal-title":"Circ Res"},{"issue":"3","key":"2257_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/14656566.2022.2161886","volume":"24","author":"SA Doggrell","year":"2023","unstructured":"Doggrell SA. A new role for an old drug: Acetazolamide in decompensated heart failure. Expert Opin Pharmacother. 2023;24(3):309\u201313.","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"2257_CR12","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1161\/CIRCULATIONAHA.122.062486","volume":"147","author":"P Martens","year":"2023","unstructured":"Martens P, Dauw J, Verbrugge FH, Nijst P, Meekers E, Augusto SN, et al. Decongestion with Acetazolamide in acute decompensated heart failure across the spectrum of left ventricular ejection fraction: A prespecified analysis from the ADVOR trial. Circulation. 2023;147(3):201\u201311.","journal-title":"Circulation"},{"issue":"24","key":"2257_CR13","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/ehad266","volume":"44","author":"W Mullens","year":"2023","unstructured":"Mullens W, Schulze PC, Westphal J, Bogoviku J, Bauersachs J. Great debate: in patients with decompensated heart failure, Acetazolamide in addition to loop diuretics is the first choice. Eur Heart J. 2023;44(24):2159\u201369.","journal-title":"Eur Heart J"},{"issue":"1","key":"2257_CR14","doi-asserted-by":"publisher","first-page":"e288","DOI":"10.3390\/jcm13010288","volume":"13","author":"M Sabina","year":"2024","unstructured":"Sabina M, Barakat Z, Feliciano A, Lamb A, Alsamman MM. Unlocking the potential of acetazolamide: A literature review of an adjunctive approach in heart failure management. J Clin Med. 2024;13(1):e288.","journal-title":"J Clin Med"},{"issue":"9","key":"2257_CR15","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s11255-020-02704-7","volume":"53","author":"A Simge","year":"2021","unstructured":"Simge A, Sueda S, Cinar O, Baris A, Sag AA, Masanari K, et al. Pharmacologic and interventional paradigms of diuretic resistance in congestive heart failure: a narrative review. Int Urol Nephrol. 2021;53(9):1839\u201349.","journal-title":"Int Urol Nephrol"},{"issue":"12","key":"2257_CR16","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.recesp.2017.02.011","volume":"70","author":"S Garc\u00eda-Blas","year":"2017","unstructured":"Garc\u00eda-Blas S, Bonanad C, Ll\u00e0cer P, Ventura S, N\u00fa\u00f1ez JM, S\u00e1nchez R, et al. Diuretic strategies in acute heart failure and renal dysfunction: conventional vs carbohydrate antigen 125-guided strategy. Clin Trial Des Rev Esp Cardiol Engl Ed. 2017;70(12):1067\u201373.","journal-title":"Clin Trial Des Rev Esp Cardiol Engl Ed"},{"issue":"3","key":"2257_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/AC.70.3.3080630","volume":"70","author":"FH Verbrugge","year":"2015","unstructured":"Verbrugge FH, Dupont M, Bertrand PB, Nijst P, Penders J, Dens J, et al. Determinants and impact of the natriuretic response to diuretic therapy in heart failure with reduced ejection fraction and volume overload. Acta Cardiol. 2015;70(3):265\u201373.","journal-title":"Acta Cardiol"},{"issue":"1","key":"2257_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/IJNRD.S135660","volume":"10","author":"M Goyfman","year":"2017","unstructured":"Goyfman M, Zamudio P, Jang K, Chee J, Miranda C, Butler J, et al. Combined Aquaretic and diuretic therapy in acute heart failure. Int J Nephrol Renov Dis. 2017;10(1):129\u201334.","journal-title":"Int J Nephrol Renov Dis"},{"issue":"6","key":"2257_CR19","doi-asserted-by":"publisher","first-page":"e12465","DOI":"10.1111\/1755-5922.12465","volume":"36","author":"J N\u00fa\u00f1ez","year":"2018","unstructured":"N\u00fa\u00f1ez J, Heredia R, Pay\u00e1 A, Sanchis I, Del Prado S, Mi\u00f1ana G, et al. Use of Acetazolamide in the treatment of patients with refractory congestive heart failure. Cardiovasc Ther. 2018;36(6):e12465.","journal-title":"Cardiovasc Ther"},{"issue":"12","key":"2257_CR20","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s40261-017-0577-1","volume":"37","author":"T Imiela","year":"2017","unstructured":"Imiela T, Budaj A. Acetazolamide as Add-on diuretic therapy in exacerbations of chronic heart failure: a pilot study. Clin Drug Investig. 2017;37(12):1175\u201381.","journal-title":"Clin Drug Investig"},{"issue":"11","key":"2257_CR21","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/ejhf.1478","volume":"21","author":"FH Verbrugge","year":"2019","unstructured":"Verbrugge FH, Martens P, Ameloot K, Haemels V, Penders J, Dupont M, et al. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance. Eur J Heart Fail. 2019;21(11):1415\u201322.","journal-title":"Eur J Heart Fail"},{"issue":"13","key":"2257_CR22","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","volume":"387","author":"W Mullens","year":"2022","unstructured":"Mullens W, Dauw J, Martens P, Verbrugge F, Nijst P, Meekers E, et al. Acetazolamide in acute decompensated heart failure with volume overload. N Engl J Med. 2022;387(13):1185\u201395.","journal-title":"N Engl J Med"},{"issue":"12","key":"2257_CR23","first-page":"e16526","volume":"133","author":"A Kosiorek","year":"2023","unstructured":"Kosiorek A, Urban S, Detyna J, Biegus J, Hurkacz M, Zymli\u0144ski R. Diuretic, natriuretic, and chloride-regaining effects of oral Acetazolamide as an add-on therapy for acute heart failure with volume overload: a single-center, prospective, randomized study. Pol Arch Intern Med. 2023;133(12):e16526.","journal-title":"Pol Arch Intern Med"},{"issue":"3","key":"2257_CR24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jchf.2023.01.011","volume":"11","author":"SJ Greene","year":"2023","unstructured":"Greene SJ, Felker GM. Considering addition of Acetazolamide to loop diuretics as treatment for acute heart failure: ADVOR reappraisal. JACC Heart Fail. 2023;11(3):365\u20137.","journal-title":"JACC Heart Fail"},{"issue":"1","key":"2257_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/eurheartj\/ehac530","volume":"44","author":"J Biegus","year":"2023","unstructured":"Biegus J, Voors AA, Collins SP, Kosiborod MN, Teerlink JR, Angermann CE, et al. Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial. Eur Heart J. 2023;44(1):41\u201350.","journal-title":"Eur Heart J"},{"issue":"6S1","key":"2257_CR26","doi-asserted-by":"publisher","first-page":"S617","DOI":"10.1016\/S1769-7255(22)00649-6","volume":"18","author":"H Bakis","year":"2022","unstructured":"Bakis H, Pfirmann P, Combe C, Rigothier C. \u00c0 Qui Un n\u00e9phrologue doit-il prescrire Un iSGLT2? Indications of SGLT2 inhibitors in kidney disease: who, why and when? Nephrol Ther. 2022;18(6S1):S617\u201324.","journal-title":"Nephrol Ther"},{"issue":"19","key":"2257_CR27","doi-asserted-by":"publisher","first-page":"e4497","DOI":"10.3390\/jcm10194497","volume":"10","author":"AM G\u00f3mez-Perez","year":"2021","unstructured":"G\u00f3mez-Perez AM, Damas-Fuentes M, Cornejo-Pareja I, Tinahones FJ. Heart failure in type 1 diabetes: A complication of concern?? A narrative review. J Clin Med. 2021;10(19):e4497.","journal-title":"J Clin Med"},{"issue":"2","key":"2257_CR28","doi-asserted-by":"publisher","first-page":"355","DOI":"10.36660\/abc.20210031","volume":"116","author":"EA Bocchi","year":"2021","unstructured":"Bocchi EA, Biolo A, Moura LZ, Figueiredo JA, Lucena-Montenegro CE, Campos D. Emerging topics in heart failure: Sodium-Glucose Co-Transporter 2 inhibitors (SGLT2i) in HF. Arq Bras Cardiol. 2021;116(2):355\u20138.","journal-title":"Arq Bras Cardiol"},{"issue":"12","key":"2257_CR29","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.4067\/s0034-98872022001201647","volume":"150","author":"A Nouel","year":"2022","unstructured":"Nouel A, Winter JL, Sep\u00falveda L. Sodium-glucose cotransporter 2 inhibitors for the management of heart failure. Rev Med Chil. 2022;150(12):1647\u201354.","journal-title":"Rev Med Chil"},{"issue":"5","key":"2257_CR30","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/eurheartj\/ehac689","volume":"44","author":"JC Trull\u00e0s","year":"2023","unstructured":"Trull\u00e0s JC, Morales-Rull JL, Casado J, Carrera-Izquierdo M, S\u00e1nchez-Marteles M, Conde-Martel A, et al. Combining loop with Thiazide diuretics for decompensated heart failure: the CLOROTIC trial. Eur Heart J. 2023;44(5):411\u201321.","journal-title":"Eur Heart J"},{"issue":"10","key":"2257_CR31","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1016\/j.jchf.2024.05.006","volume":"12","author":"M S\u00e1nchez-Marteles","year":"2024","unstructured":"S\u00e1nchez-Marteles M, Garc\u00e9s-Horna V, Morales-Rull JL, Casado J, Carrera-Izquierdo M, Conde-Martel A, et al. Combining loop and Thiazide diuretics across the left ventricular ejection fraction spectrum: the CLOROTIC trial. JACC Heart Fail. 2024;12(10):1719\u201330.","journal-title":"JACC Heart Fail"},{"issue":"2","key":"2257_CR32","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.rce.2023.11.011","volume":"224","author":"A Conde-Martel","year":"2024","unstructured":"Conde-Martel A, Trull\u00e0s JC, Morales-Rull JL, Casado J, Carrera-Izquierdo M, S\u00e1nchez-Marteles M, et al. Sex differences in clinical characteristics and outcomes in the CLOROTIC (combining loop with Thiazide diuretics for decompensated heart failure) trial. Rev Clin Esp. 2024;224(2):67\u201376.","journal-title":"Rev Clin Esp"},{"issue":"12","key":"2257_CR33","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","volume":"297","author":"M Gheorghiade","year":"2007","unstructured":"Gheorghiade M, Konstam MA, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K, et al. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST clinical status trials. JAMA. 2007;297(12):1332\u201343.","journal-title":"JAMA"},{"issue":"11","key":"2257_CR34","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.jacc.2016.09.004","volume":"69","author":"GM Felker","year":"2017","unstructured":"Felker GM, Mentz RJ, Cole RT, Adams KF, Egnaczyk GF, Fiuzat M, et al. Efficacy and safety of Tolvaptan in patients hospitalized with acute heart failure. J Am Coll Cardiol. 2017;69(11):1399\u2013406.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2257_CR35","first-page":"e37792","volume":"15","author":"BA Malik","year":"2023","unstructured":"Malik BA, Nnodebe I, Fayaz A, Inayat H, Murtaza SF, Umer M, et al. Effect of Acetazolamide as Add-On diuretic therapy in patients with heart failure: A Meta-Analysis. Cureus. 2023;15(4):e37792.","journal-title":"Cureus"},{"issue":"3","key":"2257_CR36","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1002\/ehf2.13859","volume":"9","author":"D Tomasoni","year":"2022","unstructured":"Tomasoni D, Vishram-Nielsen JK, Pagnesi M, Adamo M, Lombardi CM, Gustafsson F, et al. Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care. ESC Heart Fail. 2022;9(3):1507\u201323.","journal-title":"ESC Heart Fail"},{"issue":"31","key":"2257_CR37","doi-asserted-by":"publisher","first-page":"2966","DOI":"10.1093\/eurheartj\/ehad341","volume":"44","author":"SE Yeoh","year":"2023","unstructured":"Yeoh SE, Osmanska J, Petrie MC, Brooksbank KJ, Clark AL, Docherty KF, et al. Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics. Eur Heart J. 2023;44(31):2966\u201377.","journal-title":"Eur Heart J"},{"issue":"1","key":"2257_CR38","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10741-020-10003-7","volume":"26","author":"PS Eid","year":"2021","unstructured":"Eid PS, Ibrahim DA, Zayan AH, Elrahman MM, Shehata MA, Kandil H, et al. Comparative effects of Furosemide and other diuretics in the treatment of heart failure: a systematic review and combined meta-analysis of randomized controlled trials. Heart Fail Rev. 2021;26(1):127\u201336.","journal-title":"Heart Fail Rev"},{"issue":"18","key":"2257_CR39","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1161\/CIRCULATIONAHA.120.048739","volume":"142","author":"NA Mordi","year":"2020","unstructured":"Mordi NA, Mordi IR, Singh JS, McCrimmon RJ, Struthers AD, Lang CC. Renal and cardiovascular effects of SGLT2 Inhibition in combination with loop diuretics in patients with type 2 diabetes and chronic heart failure: the RECEDE-CHF trial. Circulation. 2020;142(18):1713\u201324.","journal-title":"Circulation"},{"issue":"5","key":"2257_CR40","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s10741-024-10417-7","volume":"29","author":"TL Milbradt","year":"2024","unstructured":"Milbradt TL, Ura-Sudo RY, Da Silva MO, Akinfenwa S, Moura B. Acetazolamide therapy in patients with acute heart failure: a systematic review and meta-analysis of randomized controlled trials. Heart Fail Rev. 2024;29(5):1039\u201347.","journal-title":"Heart Fail Rev"},{"issue":"2","key":"2257_CR41","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s40256-024-00633-9","volume":"24","author":"AK Siddiqi","year":"2024","unstructured":"Siddiqi AK, Maniya MT, Alam MT, Ambrosy AP, Fudim M, Greene SJ, et al. Acetazolamide as an adjunctive diuretic therapy for patients with acute decompensated heart failure: A systematic review and Meta-Analysis. Am J Cardiovasc Drugs. 2024;24(2):273\u201384.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"1","key":"2257_CR42","doi-asserted-by":"publisher","first-page":"e3323","DOI":"10.4212\/cjhp.3323","volume":"77","author":"BJ Wilson","year":"2024","unstructured":"Wilson BJ, Bates D. Diuretic strategies in acute decompensated heart failure: A narrative review. Can J Hosp Pharm. 2024;77(1):e3323.","journal-title":"Can J Hosp Pharm"},{"issue":"37","key":"2257_CR43","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1093\/eurheartj\/ehad557","volume":"44","author":"E Meekers","year":"2023","unstructured":"Meekers E, Dauw J, Martens P, Dhont S, Verbrugge FH, Nijst P, et al. Renal function and decongestion with Acetazolamide in acute decompensated heart failure: the ADVOR trial. Eur Heart J. 2023;44(37):3672\u201382.","journal-title":"Eur Heart J"},{"issue":"20","key":"2257_CR44","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1016\/j.jacc.2023.03.400","volume":"81","author":"FH Verbrugge","year":"2023","unstructured":"Verbrugge FH, Martens P, Dauw J, Nijst P, Meekers E, Augusto SN, et al. Natriuretic response to Acetazolamide in patients with acute heart failure and volume overload. J Am Coll Cardiol. 2023;81(20):2013\u201324.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2257_CR45","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1002\/ejhf.2968","volume":"25","author":"M Packer","year":"2023","unstructured":"Packer M, Butler J. Similarities and distinctions between Acetazolamide and sodium-glucose cotransporter 2 inhibitors in patients with acute heart failure: key insights into ADVOR and EMPULSE. Eur J Heart Fail. 2023;25(9):1537\u201343.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"2257_CR46","doi-asserted-by":"publisher","first-page":"69","DOI":"10.14740\/cr1627","volume":"15","author":"CA Umeh","year":"2024","unstructured":"Umeh CA, Mohta T, Kaur G, Truong R, Darji P, Vue C, et al. Acetazolamide and Hydrochlorothiazide in patients with acute decompensated heart failure: insights from recent trials. Cardiol Res. 2024;15(2):69\u201374.","journal-title":"Cardiol Res"},{"issue":"2","key":"2257_CR47","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.3390\/jcm13020311","volume":"13","author":"V Bilgeri","year":"2024","unstructured":"Bilgeri V, Spitaler P, Puelacher C, Messner M, Adukauskaite A, Barbieri F, et al. Decongestion in acute heart Failure-Time to rethink and standardize current clinical practice?? J Clin Med. 2024;13(2):e311.","journal-title":"J Clin Med"},{"issue":"4","key":"2257_CR48","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jchf.2017.12.017","volume":"6","author":"JJ Park","year":"2018","unstructured":"Park JJ, Kim SH, Oh IY, Choi DJ, Park HA, Cho HJ, et al. The effect of Door-to-Diuretic time on clinical outcomes in patients with acute heart failure. JACC Heart Fail. 2018;6(4):286\u201394.","journal-title":"JACC Heart Fail"},{"issue":"25","key":"2257_CR49","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1016\/j.jacc.2017.04.042","volume":"69","author":"Y Matsue","year":"2017","unstructured":"Matsue Y, Damman K, Voors AA, Kagiyama N, Yamaguchi T, Kuroda S, et al. Time-to-Furosemide treatment and mortality in patients hospitalized with acute heart failure. J Am Coll Cardiol. 2017;69(25):3042\u201351.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"2257_CR50","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.jchf.2020.05.013","volume":"8","author":"SJ Greene","year":"2020","unstructured":"Greene SJ, Triana TS, Ionescu-Ittu R, Burne RM, Gu\u00e9rin A, Borentain M, et al. In-Hospital therapy for heart failure with reduced ejection fraction in the united States. JACC Heart Fail. 2020;8(11):943\u201353.","journal-title":"JACC Heart Fail"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-025-02257-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11886-025-02257-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-025-02257-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T09:03:59Z","timestamp":1772096639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11886-025-02257-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2257"],"URL":"https:\/\/doi.org\/10.1007\/s11886-025-02257-0","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"17 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"99"}}